Literature DB >> 28342948

Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index: A Population-based Cohort Study.

Anna Andreasson1, Axel C Carlsson2, Kristina Önnerhag3, Hannes Hagström4.   

Abstract

BACKGROUND & AIMS: Obesity, commonly assessed based on body mass index (BMI), is associated with an increased risk for severe liver disease. It is not known if other measures of body composition are better determinants of risk for severe liver disease, and/or if these differ between women and men. We investigated the body composition measures that best predict the development of severe liver disease.
METHODS: We collected data from the Malmö Diet and Cancer study in Sweden, comprising 16,784 women and 10,833 (mean age, 58.1 years at baseline), and followed patients for a median 19.8 years. We analyzed data on measures of body composition including BMI, waist/hip ratio, and others. We determined whether subjects were diagnosed with severe liver disease, or died from severe liver disease, until the end of 2014 using Swedish national registers. Associations between body composition measures and severe liver disease were assessed using Cox regression models, stratified by sex and adjusted for age, alcohol consumption, smoking, education, and physical activity.
RESULTS: All studied measures of body composition were significantly associated with severe liver disease. Waist/hip ratio was the best predictor of severe liver disease in women (hazard ratio [HR] per standard deviation increment, 1.30; 95% confidence interval [CI], 1.16-1.46) and men (HR, 1.46; 95% CI, 1.31-1.63). BMI had the lowest HR in women (HR, 1.12; 95% CI, 1.00-1.27) and men (HR, 1.26; 95% CI, 1.12-1.42). The association between waist/hip ratio and development of liver disease was independent of BMI.
CONCLUSIONS: In a Swedish population-based cohort study, we associated all measures of body composition with risk of severe liver disease. However, measures of abdominal obesity were best at predicting development of severe liver disease.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body Weight; Cirrhosis; Overweight; Waist Size

Mesh:

Year:  2017        PMID: 28342948     DOI: 10.1016/j.cgh.2017.02.040

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  9 in total

1.  The prediction of colorectal cancer using anthropometric measures: A Swedish population-based cohort study with 22 years of follow-up.

Authors:  Anna Andreasson; Hannes Hagström; Filip Sköldberg; Kristina Önnerhag; Axel C Carlsson; Peter T Schmidt; Anna M Forsberg
Journal:  United European Gastroenterol J       Date:  2019-05-24       Impact factor: 4.623

Review 2.  Waist Circumference and Risk of Liver Cancer: A Systematic Review and Meta-Analysis of over 2 Million Cohort Study Participants.

Authors:  Jamal Rahmani; Hamed Kord Varkaneh; Vasileios Kontogiannis; Paul M Ryan; Hiba Bawadi; Somaye Fatahi; Yong Zhang
Journal:  Liver Cancer       Date:  2019-10-08       Impact factor: 11.740

3.  Risk Factors for Abdominal Pain-Related Disorders of Gut-Brain Interaction in Adults and Children: A Systematic Review.

Authors:  Jasmine K Zia; Adrienne Lenhart; Pei-Lin Yang; Margaret M Heitkemper; Jason Baker; Laurie Keefer; Miguel Saps; Callie Cuff; Gregory Hungria; Elizabeth J Videlock; Lin Chang
Journal:  Gastroenterology       Date:  2022-06-16       Impact factor: 33.883

4.  Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.

Authors:  Hannes Hagström; Patrik Nasr; Mattias Ekstedt; Ulf Hammar; Per Stål; Rolf Hultcrantz; Stergios Kechagias
Journal:  Hepatol Commun       Date:  2017-11-30

5.  Lean NAFLD: A not so benign condition?

Authors:  Lisa B VanWagner; Matthew J Armstrong
Journal:  Hepatol Commun       Date:  2018-01-16

6.  Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up.

Authors:  Hannes Hagström; Anna Andreasson; Axel C Carlsson; Mats Jerkeman; Mattias Carlsten
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

7.  Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.

Authors:  Helen Jarvis; Dawn Craig; Robert Barker; Gemma Spiers; Daniel Stow; Quentin M Anstee; Barbara Hanratty
Journal:  PLoS Med       Date:  2020-04-30       Impact factor: 11.069

Review 8.  Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis.

Authors:  Agostino Di Ciaula; Leonilde Bonfrate; Marcin Krawczyk; Gema Frühbeck; Piero Portincasa
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

9.  Central adiposity in relation to risk of liver cancer in Chinese adults: A prospective study of 0.5 million people.

Authors:  Yuanjie Pang; Christiana Kartsonaki; Yu Guo; Yiping Chen; Ling Yang; Zheng Bian; Fiona Bragg; Iona Y Millwood; Canqing Yu; Jun Lv; Junshi Chen; Liming Li; Michael V Holmes; Zhengming Chen
Journal:  Int J Cancer       Date:  2019-02-13       Impact factor: 7.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.